Showing results (191-200 of 420) with videos related to

Sort By:
Pageof 42
Cancer Research|January 1, 1985
Chromosomal alterations in acute leukemia patients studied with improved culture methodsJ R Testa, S Misawa, N Oguma, et al.
Medical Oncology (Northwood, London, England)|June 1, 1995
Levels of soluble interleukin-2 receptors are predictive of response in patients treated with interleukin-2 and lymphokine-activated killer cellsE Paietta, D L Nelson, J Andersen, et al.
The New England Journal of Medicine|January 8, 1976
Reverse transcriptase in leukocytes of leukemic patients in remissionM V Viola, M Frazier, P H Wiernik, et al.
Cancer Genetics and Cytogenetics|July 1, 1986
Detection of clonal karyotypic abnormalities in most patients with acute nonlymphocytic leukemia examined using short-term culture techniquesS Misawa, D E Hogge, N Oguma, et al.
American Journal of Clinical Oncology|December 18, 1998
High-dose megestrol acetate in the treatment of patients with ovarian cancer who have undergone previous treatment: Eastern Cooperative Oncology Group Study PD884P H Wiernik, E S Greenwald, H Ball, et al.
The Cancer Journal From Scientific American|November 17, 1998
Sequential phase II trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced colorectal carcinomaS Wadler, H Haynes, A Rozenblit, et al.
British Journal of Haematology|January 29, 2000
Age of onset evidence for anticipation in familial non-Hodgkin's lymphomaP H Wiernik, S Q Wang, X P Hu, et al.
Blood Reviews|March 1, 1995
Modulation of multidrug resistance in de novo adult acute myeloid leukemia: variable efficacy of reverting agents in vitro. Eastern Cooperative Oncology GroupE Paietta, J Andersen, J Racevskis, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1987
Plasma cell leukemia with an unusual karyotype and prolonged survival following oral alkylating agent therapyP H Wiernik, D Sciortino, E Paietta, et al.
Cancer|November 1, 1976
A comparison of cyclophosphamide, vincristine, and prednisone (COP) with nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) in the treatment of nodular, poorly differentiated, lymphocytic lymphomaR S Benjamin, P H Wiernik, M J O'Connell, et al.
Pageof 42